Detalles de la búsqueda
1.
Functional status predicts major complications and death after endovascular repair of abdominal aortic aneurysms.
J Vasc Surg
; 66(3): 743-750, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28259573
2.
Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes.
AJR Am J Roentgenol
; 205(5): 976-84, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26496544
3.
Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses.
Liver Transpl
; 20(6): 728-35, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24648186
4.
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer.
J Clin Oncol
; 42(10): 1193-1201, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381994
5.
Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.
Liver Transpl
; 18(1): 100-11, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21837741
6.
Is a mandatory intensive care unit stay needed after liver transplantation? Feasibility of fast-tracking to the surgical ward after liver transplantation.
Liver Transpl
; 18(3): 361-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22140001
7.
Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors.
Transpl Int
; 25(8): 838-46, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22703372
8.
Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts.
Ann Hepatol
; 11(5): 679-85, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22947529
9.
Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration.
Drug Saf
; 45(2): 169-180, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113347
10.
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.
Clin Cancer Res
; 28(11): 2221-2228, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101885
11.
Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
Liver Transpl
; 17(6): 641-9, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21618684
12.
Should donation after cardiac death liver grafts be used for retransplantation?
Ann Hepatol
; 10(4): 482-5, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21911889
13.
The Impact of Variability in Patient Exposure During Premarket Clinical Development on Postmarket Safety Outcomes.
Clin Pharmacol Ther
; 110(6): 1512-1525, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34057195
14.
Postmarketing Safety-Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002-2014: Similarities and Differences With New Molecular Entities.
Clin Pharmacol Ther
; 108(6): 1243-1253, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557564
15.
Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries.
Sleep
; 42(4)2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649500
16.
Agonal period in donation after cardiac death donors.
Transpl Int
; 26(3): e17-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23405915
17.
Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients.
Transplantation
; 93(10): 1006-12, 2012 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22357174
Resultados
1 -
17
de 17
1
Próxima >
>>